The Swiss Times - Swiss News in English

Moderna Submits Application for Updated Covid Vaccine

Moderna, a biotechnology company based in the US, has submitted an application for approval of its updated Covid-vaccine in Switzerland. The XBB.1.5-vaccine is said to trigger an immune response against the XBB-lineage of Coronaviruses. Preliminary clinical tests have shown that the vaccine is effective against the XBB-variants of Covid-19 currently circulating in Switzerland. The World Health Organisation (WHO) has stated that the original strain and related variants of the Coronavirus are no longer circulating in humans. Global regulatory and health authorities have recommended updating Covid-vaccines to XBB.1.5-variants for a robust immune response against currently circulating variants. Moderna has presented a pre-clinical trial and preliminary clinical studies to Swissmedic, the Swiss regulatory authority, showing the vaccine to be effective against XBB-sub-lines.

©Keystone/SDA

Most Read

Delivery Services in Switzerland Have New Competition

22 February 2024
Delivery service
An Austrian company opens it's first online supermarket outside the country. Targeting the greater Zurich area.

Murder in Frauenfeld: Trial for the Murder of an Egyptian

22 February 2024
Murder in Frauenfeld
Two men face murder charges over the 2007 killing of a 27-year-old Egyptian, whose body was discovered submerged in Barchetsee.

Swiss Semi-Conductor Government Initiative: Will it Work?

23 February 2024
Swiss semiconductor
SwissChips Initiative represents Switzerland's strategic move to bolster its semiconductor industry amidst global competition.

Swiss CEO Vranckx Moves to the Lufthansa Executive Board

23 February 2024
Swiss CEO
Swiss CEO Dieter Vranckx moves to Lufthansa as Chief Commercial Officer, after leading Swiss through challenging times.

Stay in Touch!

Noteworthy

Swiss biotech
Swiss Biotech Firm Idorsia: Stock Soars – but Why?
26 February 2024
Decathlon
Decathlon Opens 5 more Stores in Switzerland
26 February 2024